Equities analysts expect AMERISAFE, Inc. (NASDAQ:AMSF) to report earnings of $0.86 per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for AMERISAFE’s earnings. The highest EPS estimate is $0.99 and the lowest is $0.73. AMERISAFE reported earnings of $1.22 per share during the same quarter last year, which indicates a negative year over year growth rate of 29.5%. The firm is scheduled to report its next quarterly earnings results on Wednesday, February 23rd.
According to Zacks, analysts expect that AMERISAFE will report full-year earnings of $3.68 per share for the current fiscal year, with EPS estimates ranging from $3.55 to $3.80. For the next year, analysts expect that the firm will post earnings of $2.85 per share, with EPS estimates ranging from $2.75 to $2.95. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research firms that that provide coverage for AMERISAFE.
AMERISAFE (NASDAQ:AMSF) last released its earnings results on Tuesday, October 26th. The insurance provider reported $1.02 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.77 by $0.25. The company had revenue of $73.82 million for the quarter, compared to analysts’ expectations of $76.42 million. AMERISAFE had a return on equity of 17.07% and a net margin of 27.85%. During the same quarter in the previous year, the firm posted $1.16 EPS.
AMSF stock traded down $0.56 on Thursday, reaching $55.91. The company had a trading volume of 48,148 shares, compared to its average volume of 78,999. AMERISAFE has a 1 year low of $53.50 and a 1 year high of $67.10. The company’s fifty day moving average is $57.32 and its 200 day moving average is $58.92. The company has a market cap of $1.08 billion, a P/E ratio of 11.95 and a beta of 0.35.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 17th. Investors of record on Friday, December 3rd will be paid a dividend of $0.29 per share. The ex-dividend date is Thursday, December 2nd. This represents a $1.16 dividend on an annualized basis and a dividend yield of 2.07%. AMERISAFE’s dividend payout ratio is presently 24.79%.
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Captrust Financial Advisors increased its stake in shares of AMERISAFE by 121.2% during the third quarter. Captrust Financial Advisors now owns 2,666 shares of the insurance provider’s stock valued at $150,000 after acquiring an additional 1,461 shares during the period. BNP Paribas Arbitrage SA increased its stake in shares of AMERISAFE by 136.4% during the third quarter. BNP Paribas Arbitrage SA now owns 20,344 shares of the insurance provider’s stock valued at $1,143,000 after acquiring an additional 11,737 shares during the period. Two Sigma Advisers LP grew its position in AMERISAFE by 213.3% in the third quarter. Two Sigma Advisers LP now owns 43,182 shares of the insurance provider’s stock worth $2,425,000 after buying an additional 29,400 shares during the last quarter. Two Sigma Investments LP grew its position in AMERISAFE by 121.4% in the third quarter. Two Sigma Investments LP now owns 41,999 shares of the insurance provider’s stock worth $2,359,000 after buying an additional 23,033 shares during the last quarter. Finally, Millennium Management LLC grew its position in AMERISAFE by 96.5% in the third quarter. Millennium Management LLC now owns 36,602 shares of the insurance provider’s stock worth $2,056,000 after buying an additional 17,972 shares during the last quarter. Institutional investors and hedge funds own 96.69% of the company’s stock.
AMERISAFE Company Profile
AMERISAFE, Inc is a holding company, which engages the provision of workers’ compensation insurance focused on small to mid-sized employers. It focuses on the businesses in construction, Marine, oil and gas, trucking, logging and lumber, manufacturing, and agriculture. The company was founded by Millard E.
Read More: QQQ ETF
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for AMERISAFE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMERISAFE and related companies with MarketBeat.com's FREE daily email newsletter.